A complete cure from an HIV-infection is currently not available. At present, lifelong treatment regimes are required to block the outbreak of AIDS, and these treatments do not eliminate the integrated provirus from infected cells. Now, scientists from the Heinrich-Pette-Institute for Experimental Virology and Immunology (HPI) in Hamburg and the Max-Planck-Institute of Molecular Cell Biology und Genetics in Dresden (MPI-CBG) have developed an enzyme that specifically cuts out the viral genome and eradicates the virus from the host cell. (Science, June, 29th 2007)
HIV introduces its genetic material into the DNA of body cells permanently. In particular, the immune cells are doomed due to the production of new viruses. The teams of Joachim Hauber from the HPI and Frank Buchholz from the MPI-CBG have now succeeded in specifically removing the viral DNA from infected cells. "We got rid of the virus from the infected cells; nobody has done this before", the scientists commented.
To achieve this result they genetically engineered a recombinase, an enzyme that works like molecular scissors. Recombinases cut and paste DNA sequences at specific sites. "Naturally occurring recombinases do not recognize viral sequences and are therefore not useful for an anti-viral approach", said Buchholz: "So we had to develop a recombinase that recognizes the viral sequence and removes the virus with precision."
The molecular biologists started from a recombinase that naturally is found in a bacteriophage. This enzyme, termed "Cre", does not recognize sequences from the HIV genome. Using the forces of evolution the scientists used more than 120 generation cycles to breed the enzyme "Tre", which is now able to recognize HIV sequences.
"Although Tre has so far only been tested in tissue culture cells, this work lays the technical foundation for a novel therapeutic approach that one day might be used to eradicate the HIV from cells of infected patients" said Hauber. However, it is still a long way until this approach can be used in clinical practice. "We will first go back to the bench to further improve the enzyme and then test whether the recombinase can be delivered efficiently and safely to cells in the human body", said Buchholz and Hauber.Original publication
Novel mechanisms of action discovered for the skin cancer medication Imiquimod
21.10.2016 | Technische Universität München
Second research flight into zero gravity
21.10.2016 | Universität Zürich
Researchers from the Institute for Quantum Computing (IQC) at the University of Waterloo led the development of a new extensible wiring technique capable of controlling superconducting quantum bits, representing a significant step towards to the realization of a scalable quantum computer.
"The quantum socket is a wiring method that uses three-dimensional wires based on spring-loaded pins to address individual qubits," said Jeremy Béjanin, a PhD...
In a paper in Scientific Reports, a research team at Worcester Polytechnic Institute describes a novel light-activated phenomenon that could become the basis for applications as diverse as microscopic robotic grippers and more efficient solar cells.
A research team at Worcester Polytechnic Institute (WPI) has developed a revolutionary, light-activated semiconductor nanocomposite material that can be used...
By forcefully embedding two silicon atoms in a diamond matrix, Sandia researchers have demonstrated for the first time on a single chip all the components needed to create a quantum bridge to link quantum computers together.
"People have already built small quantum computers," says Sandia researcher Ryan Camacho. "Maybe the first useful one won't be a single giant quantum computer...
COMPAMED has become the leading international marketplace for suppliers of medical manufacturing. The trade fair, which takes place every November and is co-located to MEDICA in Dusseldorf, has been steadily growing over the past years and shows that medical technology remains a rapidly growing market.
In 2016, the joint pavilion by the IVAM Microtechnology Network, the Product Market “High-tech for Medical Devices”, will be located in Hall 8a again and will...
'Ferroelectric' materials can switch between different states of electrical polarization in response to an external electric field. This flexibility means they show promise for many applications, for example in electronic devices and computer memory. Current ferroelectric materials are highly valued for their thermal and chemical stability and rapid electro-mechanical responses, but creating a material that is scalable down to the tiny sizes needed for technologies like silicon-based semiconductors (Si-based CMOS) has proven challenging.
Now, Hiroshi Funakubo and co-workers at the Tokyo Institute of Technology, in collaboration with researchers across Japan, have conducted experiments to...
14.10.2016 | Event News
14.10.2016 | Event News
12.10.2016 | Event News
21.10.2016 | Health and Medicine
21.10.2016 | Information Technology
21.10.2016 | Materials Sciences